McGrath Mac VideoLaryngoscope vs the Macintosh Laryngoscope
NCT ID: NCT02292901
Last Updated: 2016-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
158 participants
INTERVENTIONAL
2014-11-30
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Macintosh laryngoscope
Tracheal intubation will be performed using a Macintosh laryngoscope
Macintosh laryngoscope
McGrath Mac videolaryngoscope
Tracheal intubation will be performed using a McGrath Mac videolaryngoscope
McGrath Mac videolaryngoscope
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Macintosh laryngoscope
McGrath Mac videolaryngoscope
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* necessity of a rapid sequence induction
* contra-indication to sufentanil, to propofol, or to atracurium
* ENT, thoracic surgery, or intracranial surgery
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hopital Foch
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel Chandon, MD
Role: PRINCIPAL_INVESTIGATOR
Hopital Foch
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Hospitalier Franco-Britannique
Levallois-Perret, Hauts de Seine, France
Hopital Foch
Suresnes, Hauts de Seine, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A01307-38
Identifier Type: OTHER
Identifier Source: secondary_id
2013/42
Identifier Type: -
Identifier Source: org_study_id